HealthCor Management »

Penumbra shares owned by HealthCor Management

Quarter-by-quarter ownership of Penumbra (PEN) shares owned by HealthCor Management from 13F filings

Historical chart of HealthCor Management investment in Penumbra

Tip: Access up to 7 years of quarterly data

All positions including Penumbra held by HealthCor Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Penumbra by HealthCor Management

Quarter filed Position value Share count Share price at filing
2022-12-31 $1.1M 5.0k 222.46

More positions owned by HealthCor Management

BioMarin Pharmaceutical (BMRN)
Dex (DXCM)
Cytokinetics Com New (CYTK)
Acrivon Therapeutics Common Stock (ACRV)
Hyperfine Com Cl A (HYPR)
Alkermes SHS (ALKS)
CONMED Corporation (CNMD)
Neurocrine Biosciences (NBIX)
Syndax Pharmaceuticals (SNDX)
Chinook Therapeutics
Intuitive Surgical Com New (ISRG)
Blueprint Medicines (BPMC)
Geron Corporation (GERN)
Penumbra (PEN)
Rocket Pharmaceuticals (RCKT)

View all positions for HealthCor Management

Top funds holding Penumbra

FMR
BlackRock
Vanguard Group
T. Rowe Price Associates
Champlain Investment Partners
State Street Corporation
William Blair Investment Management
Rtw Investments
ClearBridge Advisors
Henderson Group
Geode Capital Management
Congress Asset Management
Baillie Gifford & Co
Capital World Investors
Citadel Advisors

View all funds holding Penumbra